Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development 167

Drug Development Pharmaceuticals Life Science Digital Health 167

Digital Health Global

JANUARY 8, 2024

Top-10 global pharmaceutical companies are already benefiting from Medable’s novel technology, shaving weeks off build times. Learn more and join Medable in San Francisco on Tuesday, January 9th for a panel discussion, “Investing in the Future of AI-Powered Clinical Research” during the 42nd JP Morgan Healthcare conference.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care.

BioTech 107

BioTech Life Science Drug Development Patient Experience 107

Digital Health Today

AUGUST 7, 2019

They have the potential to become a game changer in healthcare for patients, healthcare professionals, pharmaceuticals and insurance companies. The Digital Therapeutics Alliance developed a definition to differentiate DTx solutions from health and wellness apps. When working with pharmaceuticals, stick to pharma deal structure.

Pharmaceuticals 70

Pharmaceuticals Digital Health Drug Development Primary Care 70

mHealth Insight

APRIL 24, 2018

On Thursday the 26th April 2018 we’ll be presenting on Mobile First Clinical Trial Design at the Global Clinical Trials Connect 2018 Conference in London. With the right commitment and attention to detail, contract research organizations (CROs) and pharmaceutical companies can drive collaboration with greater efficiency.

Pharmaceuticals 28

Pharmaceuticals Drug Development 28

Insulin Nation

JULY 14, 2015

DiMasi, PhD, who analyzes the economics of health care at the Tufts University Center for the Study of Drug Development. We’ve seen very large trials and lengthening clinical development times, which would suggest larger than average development costs,” DiMasi said. There I listened to a presentation of Joseph A.

Public Health 81

Public Health Drug Development Pharmaceuticals 81